ESTRELLA IMMUNOPHARMA, INC. (ESLAW) Operating income 2021–2025
ESTRELLA IMMUNOPHARMA, INC. (ESLAW) annual operating income history from SEC filings — each fiscal year as reported.
-$13.1MFY2025 · since FY2021: -$249,146 → -$13.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$13.1M | -78.7% |
| FY2024 | -$7.3M | +34.2% |
| FY2023 | -$11.1M | -608.1% |
| FY2022 | -$1.6M | -530.0% |
| FY2021 | -$249,146 | — |
Source: SEC XBRL filings · For reference only · Not investment advice